June 2nd, 2022
THE ‘METHAMFENTANYL’ WAVE: TARGETED TREATMENTS TOWARDS THE METHAMPHETAMINE PIECE
Javier Ballester, MD
Last year the USA suffered from the highest number of overdoses by drugs in history (˂100,000 people). Methamphetamine use has been one of the main actors fueling this unprecedented catastrophe. After briefly reviewing the differences in the distribution of psychostimulant problems across the nation, we will review the current and most evidence-based interventions in the treatment of methamphetamine use disorder, including both psychosocial and psycho-pharmacological approaches, with a brief look into different interventions in development. We will finally understand the need to implement harm reduction strategies, using different guidelines from national organizations, and to individualize these treatments to minority populations that are being disproportionally affected by this tragedy.
As a result of attending this program, individuals will be able to:
(1) Review differences in epidemiological distribution of methamphetamine addiction in the USA and the role that methamphetamine is playing in fueling the latest wave of the opioid epidemic national crisis; then,
(2)Explain the current, most evidence-based psychobiological treatments in meth use disorder, harm reduction strategies, and the impact of meth on minorities.